TARSTarsus Pharmaceuticals, Inc.
72.70USD-1.01%Mkt Cap: 3.19B $P/E: —3d ago
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotil…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap3.19B $
Enterprise Value2.78B $
Revenue (TTM)606.33M $
Gross Profit420.68M $
Net Income (TTM)-66.42M $
Revenue/Share14.12 USD
Last Price72.70 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees370
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)30.75
PEG—
EV/EBITDA-60.10
EV/Revenue4.58
P/S5.17
P/B8.81
EPS (TTM)-1.04
EPS (Forward)2.33
52W Range
48.2066% of range85.25
52W High85.25 USD
52W Low48.20 USD
Profitability
Gross Margin93.20%
Oper. Margin-11.45%
EBITDA Margin-7.62%
Profit Margin-14.72%
ROE-19.34%
ROA-11.81%
Growth
Revenue Growth69.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.45M $
CapEx (TTM)9.86M $
FCF Margin11.13%
FCF Yield2.11%
Net Debt-360.88M $
Net Debt/EBITDA7.81
Balance Sheet
Debt/Equity0.21
Current Ratio3.20
Quick Ratio3.12
Book Value/Sh8.111 USD
Cash/Share10.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)94.86 USD
Upside (mean)+30.5%
Target Range84.00 USD – 104.00 USD
$84.00+30.5% to mean$104.00
# Analysts7
Ownership
Shares Out.43.88M
Float32.68M
Insiders2.86%
Institutions106.08%
Short Interest
Short Ratio4.5d
Short % Float14.16%
Short % Out.13.71%
Shares Short6.02M
Short (prev mo.)5.89M
Technical
SMA 5063.14 (+15.1%)
SMA 20068.50 (+6.1%)
Beta0.51
S&P 52W Chg18.16%
Avg Vol (30d)928.16K
Avg Vol (10d)723.48K
Technical Indicators
RSI (14)69.6
MACD3.0204
MACD Signal1.9424
MACD Hist.+1.0780
BB Upper75.06 USD
BB Middle64.47 USD
BB Lower53.87 USD
BB Width32.88%
ATR (14)3.154 USD
Vol Ratio (20d)0.82x